Sovaldi
NDC 61958-1504, SOFOSBUVIR, pellet, from Gilead Sciences, Inc..
- Product NDC
- 61958-1504
- Status
- Listed
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- PELLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212480
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61958-1504 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SOFOSBUVIR150 mg/1
Pharmacologic classes
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]; RNA Replicase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61958-1504-1 | 61958150401 | 60 PELLET in 1 PACKET (61958-1504-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/80beab2c-396e-4a37-a4dc-40fdb62859cf
Use it
Look up 61958-1504 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61958-1504 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61958-1504. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.